|
As part of Methodist Hospital Texsan's continued efforts to prevent strokes in South Texas, the hospital announced Oct. 23 that its Cardiac Electrophysiology, or EP, team has successfully performed over 1,200 left atrial appendage closure, or LAAC, implant procedures on eligible patients with atrial fibrillation, or AFib.
In a nutshell: According to a news release, the program's milestone is due to the use of evidence-based practices and collaboration centered on safety and outcomes. The procedure is FDA-approved and is ideal for AFib patients who are not good candidates for long-term anticoagulation, or blood-thinner, therapy.
The procedure seals the left atrial appendage—a small pouch where clots commonly form in AFib. According to the release, a successful procedure reduces the risk that a clot will move to the brain and induce a stroke.
Why it matters: According to the release, LAAC is a way for certain patients to stop long-term blood thinner therapy, which can help many older adults who are at a higher risk of falls and bleeding.
|